<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-INR-16008037</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2016-03-02</date_registration>
      <primary_sponsor>Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</primary_sponsor>
      <public_title>Treatment of hUC-MSC for neuromyelitis optica spectrum disorder- A prospective multicenter randomized controlled study</public_title>
      <acronym />
      <scientific_title>Treatment of hUC-MSC for neuromyelitis optica spectrum disorder- A prospective multicenter randomized controlled study</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2016-04-01</date_enrolment>
      <type_enrolment />
      <target_size>intervention group:200;congtrol group:200;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=13545</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>neuromyelitis optica spectrum disorder</hc_freetext>
      <i_freetext>intervention group:regular drug treatment plus hUC-MSC;congtrol group:regular drug treatment;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>LI ZEZHI</firstname>
        <middlename />
        <lastname />
        <address>1630 Dongfang Road,  Shanghai, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13501796424</telephone>
        <email>13564648631@126.com</email>
        <affiliation>Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>GUAN YANGTAI</firstname>
        <middlename />
        <lastname />
        <address>1630 Dongfang Road,  Shanghai, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13386271865</telephone>
        <email>yangtaiguan@sina.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. aged &gt;=18 years;
2. a new focal neurological deficits;
3. met diagnostic criteria of NMOSD;
4. normal liver and kidney function, blood cell, urine  examination;
5. written informed consents were obtained from all subjects.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>90</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. abnormal expression or disturbance of consciousness,instable vital signs;
2. diabetes, hyperthyroidism and other endocrine disorders;
3. severe mental illness patients who cannot be cooperated;
4. patients with severe liver or kidney disease and severe systemic chronic wasting disease;
5. gastrointestinal or other bleeding disorder within a mongth;
6. history of myelodysplastic syndrome;
7. use of non steroidal anti-inflammatory drugs;
8. plaque decrease by using injection of heparin or low molecular weight heparin or heparin;
9. history of relative drug allergy;
10. history of important surgeries a week ago;
11. can not cooperate in clinical trial. </exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Recurrent events of the clinical symptoms;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Found from multi-center clinical trial of School of Medicine, Shanghai Jiao Tong University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-02-29</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>